Methotrexat Ebewe

Methotrexate, the active ingredient in Methotrexat Ebewe, is a Antimetabolite presented as an oral formulation for Oral use. It is employed to manage autoimmune disorders and certain cancers by interfering with cell proliferation. GNH USA supplies Methotrexat Ebewe as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methotrexat Ebewe is an antimetabolite that modulates immune activity and cancer cell growth. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin plaque formation and severity. - Acute lymphoblastic leukemia: inhibits leukemic cell replication as part of chemotherapy protocols. - Osteosarcoma: impedes tumor growth when used in combination regimens.

Methotrexat Ebewe may cause a range of adverse reactions.

Common Side Effects: - Nausea or vomiting - Fatigue or malaise - Mouth sores (stomatitis) - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Severe liver toxicity or hepatitis - Pulmonary fibrosis or interstitial pneumonitis - Bone marrow suppression resulting in severe anemia or neutropenia - Acute renal failure or nephrotoxicity - Life‑threatening skin reactions such as Stevens‑Johnson syndrome

Patients receiving Methotrexat Ebewe should be monitored for safety and appropriate use. - Monitor liver function: perform regular hepatic enzyme tests. - Monitor blood counts: check complete blood count to detect marrow suppression. - Avoid use in pregnancy: drug is contraindicated due to teratogenic risk. - Adjust dose in renal impairment: assess renal function before and during therapy. - Counsel on infection risk: advise patients to report signs of infection promptly. - Store at room temperature: keep in the original pack, protect from moisture.

Methotrexat Ebewe can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - NSAIDs: increase risk of methotrexate toxicity. - Penicillins: may enhance bone‑marrow suppression. - Live vaccines: heightened risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Sulfonamides: may potentiate hematologic toxicity. - Trimethoprim: can increase methotrexate serum levels. - Allopurinol: may exacerbate myelosuppression.